Moricizine: a review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias

A Fitton, MMT Buckley - Drugs, 1990 - Springer
Synopsis Moricizine (moracizine, ethmozine) is an orally active phenothiazine derivative
with direct myocardial Class I antiarrhythmic activity and minimal CNS effects. Placebo …

Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology

EM Antman, JMO Arnold, PL Friedman… - Cardiovascular drugs and …, 1987 - Springer
While preliminary screening for interactions between new cardiovascular
pharmacotherapeutic agents and digoxin can be efficiently and safely conducted in normal …

Moricizine: a novel antiarrhythmic agent

CA Carnes, JD Coyle - DICP, 1990 - journals.sagepub.com
Moricizine is a phenothiazine derivative with Vaughan Williams class 1 antiarrhythmic
properties. It undergoes extensive first-pass metabolism, has a bioavailability of 34–38 …

Positive inotropic drugs and drugs used in dysrhythmias

JK Aronson - Side Effects of Drugs Annual, 1988 - Elsevier
Publisher Summary The main difficulty in diagnosing digitalis toxicity is the non-specificity of
most of the signs and symptoms. An attempt has been made to determine whether there are …

Positive inotropic drugs and drugs used in dysrhythmias

JK Aronson - Side Effects of Drugs Annual, 1993 - Elsevier
Publisher Summary This chapter discusses several positive inotropic drugs and drugs used
in dysrhythmias. Plasma potassium concentrations normally rise during exercise. In the …

[引用][C] POSITIVE INOTROPIC DRUGS Cardiac glycosides (SED-11, 333; SEDA-12, 148) The mechanisms of action and clinical use of digitalis have again been …

MNG Dukes, L Beeley - Side Effects of Drugs Annual, 1977 - Excerpta Medica